Non Segmental Vitiligo
Dermatology
1
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
1
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2025
2026
2027
2028
2029
InnoCareICP-332 Tablets
Clinical Trials (1)
Total enrollment: 603 patients across 1 trials
ICP-332 in Subjects With Non-segmental Vitiligo
Start: May 2025Est. completion: Apr 2029603 patients
Phase 2/3Recruiting
Related Jobs in Dermatology
MSL/Senior MSL, Dermatology - Tampa, Florida
AbbVie
Remote
13h ago
(Senior) Außendienstmitarbeiter Dermatology (all genders) - Region Thüringen
AbbVie
Remote
13h ago
Regional Sales Trainer - Dermatology (Central / West Regions)
AbbVie
Remote
14h ago
Regional Sales Trainer - Dermatology (Northeast / Southeast Regions)
AbbVie
Remote
14h ago
Delegado Especialista Ventas Dermatología (Inmunología)
AbbVie
Remote
18h ago
Senior Manager, HTA, Value and Evidence (HV&E), Medical Dermatology
Pfizer
United States - New York - New York City
Yesterday
$139K - $232K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 603 patients
1 companies competing in this space